Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
"In the brain, it's thought to reduce food intake by some element of appetite suppression," says Evan Nadler, MD, MBA , former co-director of the obesity program at Children's National Hospital and current adjunct associate professor at George Washington University
Being an informed, proactive patient on this topic leads to meaningfully better outcomes
Eli Lilly and Company is currently researching a dual agonist called tirzepatide, which has outperformed semaglutide in phase 3 clinical trials
My hunger throughout the day has dampened significantly, making it easier to focus on healthier options
Effect estimates were reported as ORs with 95% CIs
Illustration by Donnisa Edmonds
US$ 28.89
US$ 27.03
US$ 20.19
US$ 25.74
US$ 22.63
